Skip to main content

Wall Street is being nicer on earnings as vaccine makers, fintech reports approach

With a downcast earnings season passing the halfway mark, results from pharma and fintech companies will dominate the week ahead.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.